"Aldosterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.
Descriptor ID |
D000450
|
MeSH Number(s) |
D04.210.500.745.745.654.062 D06.472.040.585.353.118
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aldosterone".
Below are MeSH descriptors whose meaning is more specific than "Aldosterone".
This graph shows the total number of publications written about "Aldosterone" by people in this website by year, and whether "Aldosterone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 6 | 7 | 13 |
2018 | 6 | 3 | 9 |
2019 | 2 | 3 | 5 |
2020 | 3 | 3 | 6 |
2021 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Aldosterone" by people in Profiles.
-
Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations. J Hypertens. 2021 08 01; 39(8):1725-1726.
-
Endocrine and metabolic aspects of COVID-19. Endokrynol Pol. 2021; 72(3):256-260.
-
Effect of Reducing Sedentary Behavior on Blood Pressure (RESET BP): Rationale, design, and methods. Contemp Clin Trials. 2021 07; 106:106428.
-
Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19. Am J Hypertens. 2021 04 02; 34(3):278-281.
-
How Important Is the Assessment of Soluble ACE-2 in COVID-19? Am J Hypertens. 2021 04 02; 34(3):296-297.
-
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. Eur J Heart Fail. 2021 03; 23(3):486-488.
-
Associastion of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19. Adv Exp Med Biol. 2021; 1327:205-214.
-
Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysis. Eur J Heart Fail. 2021 03; 23(3):476-485.
-
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2. J Endocrinol. 2020 11; 247(2):R45-R62.
-
Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity. Heart. 2020 10; 106(19):1451-1453.